跳到正文
openFDA 已分级药品召回执法报告·· 19 天前AI 评分59

FDA 执法报告 D-0113-2027:MSN Laboratories Unit-II 阿托伐他汀钙片因混入外来片剂或胶囊被定为 II 类召回

FDA drug enforcement D-0113-2027: MSN Laboratories Private Limited (Formulations Division, Unit-II) — Presence of Foreign Tablets/Capsules

AI 导读

FDA 执法报告 D-0113-2027 将 MSN Laboratories Private Limited 制剂部 Unit-II 生产的阿托伐他汀钙片 40mg 定为 II 类召回,原因为混入外来片剂或胶囊。

正文 · 原文

FDA drug recall enforcement report — D-0113-2027

Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "Survey # 1277, 1319-1324",

"address_2": "Nandigama (Village & Mandal)",

"center_classification_date": "20261029",

"city": "Rangareddy District",

"classification": "Class II",

"code_info": "Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.",

"country": "India",

"distribution_pattern": "Nationwide in the USA.",

"event_id": "100172",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA211933"

],

"brand_name": [

"ATORVASTATIN CALCIUM"

],

"generic_name": [

"ATORVASTATIN CALCIUM"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Novadoz Pharmaceuticals LLC"

],

"package_ndc": [

"72205-022-30",

"72205-022-90",

"72205-022-05",

"72205-022-99",

"72205-023-30",

"72205-023-90",

"72205-023-05",

"72205-023-99",

"72205-024-30",

"72205-024-90",

"72205-024-05",

"72205-024-99",

"72205-025-30",

"72205-025-90",

"72205-025-05",

"72205-025-99"

],

"product_ndc": [

"72205-022",

"72205-023",

"72205-024",

"72205-025"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"ORAL"

],

"rxcui": [

"259255",

"617310",

"617311",

"617312"

],

"spl_id": [

"11823aa6-547f-4c0b-983a-65b837f94e89"

],

"spl_set_id": [

"bc448f40-421c-490f-8c39-fa8135507973"

],

"substance_name": [

"ATORVASTATIN CALCIUM TRIHYDRATE"

],

"unii": [

"48A5M73Z4Q"

],

"upc": [

"0372205025905",

"0372205025059",

"0372205024052"

]

},

"postal_code": "N/A",

"product_description": "Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99",

"product_quantity": "13,296 1,000-count bottles",

"product_type": "Drugs",

"reason_for_recall": "Presence of Foreign Tablets/Capsules",

"recall_initiation_date": "20261021",

"recall_number": "D-0113-2027",

"recalling_firm": "MSN Laboratories Private Limited (Formulations Division, Unit-II)",

"report_date": "20261104",

"state": "",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov